Anti-angiogenic therapy for metastatic colorectal cancer

Yoshihiro Kakeji, Beverly A. Teicher, Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents Investigational New Drugs. ,vol. 15, pp. 39- 48 ,(1997) , 10.1023/A:1005718628223

David Lyden, Koichi Hattori, Sergio Dias, Carla Costa, Pamela Blaikie, Linda Butros, Amy Chadburn, Beate Heissig, Willy Marks, Larry Witte, Yan Wu, Daniel Hicklin, Zhenping Zhu, Neil R. Hackett, Ronald G. Crystal, Malcolm A.S. Moore, Katherine A. Hajjar, Katia Manova, Robert Benezra, Shahin Rafii, Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth Nature Medicine. ,vol. 7, pp. 1194- 1201 ,(2001) , 10.1038/NM1101-1194

Napoleone Ferrara, Kenneth J Hillan, Hans-Peter Gerber, William Novotny, None, Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer Nature Reviews Drug Discovery. ,vol. 3, pp. 391- 400 ,(2004) , 10.1038/NRD1381

R. Longo, R. Sarmiento, M. Fanelli, B. Capaccetti, D. Gattuso, G. Gasparini, Anti-angiogenic therapy: Rationale, challenges and clinical studies Angiogenesis. ,vol. 5, pp. 237- 256 ,(2002) , 10.1023/A:1024532022166

W Scheithauer, H Rosen, G V Kornek, C Sebesta, D Depisch, Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. BMJ. ,vol. 306, pp. 752- 755 ,(1993) , 10.1136/BMJ.306.6880.752

Kenneth F Schulz, Iain Chalmers, David A Grimes, Douglas G Altman, Assessing the Quality of Randomization From Reports of Controlled Trials Published in Obstetrics and Gynecology Journals JAMA: The Journal of the American Medical Association. ,vol. 272, pp. 125- 128 ,(1994) , 10.1001/JAMA.1994.03520020051014

Louis M. Sherwood, Edith E. Parris, Judah Folkman, Tumor Angiogenesis: Therapeutic Implications New England Journal of Medicine. ,vol. 285, pp. 1182- 1186 ,(1971) , 10.1056/NEJM197111182852108

Isaiah J Fidler, Lee M Ellis, The implications of angiogenesis for the biology and therapy of cancer metastasis Cell. ,vol. 79, pp. 185- 188 ,(1994) , 10.1016/0092-8674(94)90187-2

Douglas Hanahan, Judah Folkman, Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis Cell. ,vol. 86, pp. 353- 364 ,(1996) , 10.1016/S0092-8674(00)80108-7

Alejandro R. Jadad, R.Andrew Moore, Dawn Carroll, Crispin Jenkinson, D.John M. Reynolds, David J. Gavaghan, Henry J. McQuay, Assessing the quality of reports of randomized clinical trials : is blinding necessary? Controlled Clinical Trials. ,vol. 17, pp. 1- 12 ,(1996) , 10.1016/0197-2456(95)00134-4